Anderson, C. M., Lee, C. M., Saunders, D., Curtis, A. E., Dunlap, N. E., Nangia, C., Lee, A.S., Kovoor, P., Bar-Ad, V., Pedadda, A.V., Holmlund, J., Downs, M., & Sonis, S. T. (2022). Two-year tumor outcomes of a phase 2B, randomized, double-blind trial of avasopasem manganese (GC4419) versus placebo to reduce severe oral mucositis owing to concurrent radiation therapy and cisplatin for head and neck cancer. International Journal of Radiation Oncology Biology Physics, 114(3),416-421. https://doi.org/10.1016/j.ijrobp.2022.06.063
Goh, E. Z., Beech, N., Johnson, N. R., & Batstone, M. (2023). The dental management of patients irradiated for head and neck cancer. British Dental Journal, 234, 800–804. https://doi.org/10.1038/s41415-023-5864-z
Kutuk, T., Atak, E., Villa, A., Kalman, N. S., & Kaiser, A. (2024). Interdisciplinary collaboration in head and neck cancer care: Optimizing oral health management for patients undergoing radiation therapy. Current Oncology, 31(4), 2092–2108. https://doi.org/10.3390/curroncol31040155
Nath, J., Singh, P. K., & Sarma, G. (2022). Dental care in head and neck cancer patients undergoing radiotherapy. Indian Journal of Otolaryngology and Head & Neck Surgery, 74(3), 6219–6224. https://doi.org/10.1007/s12070-021-02941-x
Yin, J., Xie, J., Lin, J., Weng, C., Lu, S., Xu, P., Zhang, S., Luo, C., Huang, Y., Li, L., Lang, J., & Feng, M. (2022). Evaluation of the efficacy of the anti-ulcer oral mucosal protective agent RADoralex® in the prevention and treatment of radiation-induced oral mucosal reactions induced during treatment of nasopharyngeal carcinoma. Cancer Biology & Therapy, 23(1), 27-33. https://doi.org/10.1080/15384047.2021.2013704